| 2026-05-08 |
详情>>
业绩披露：
2026年一季报每股收益0.49美元,归母净利润1.15亿美元,同比去年增长-23.82%
|
| 2026-05-07 |
财报披露：
美东时间 2026-05-07 盘后发布财报
|
| 2026-04-30 |
详情>>
内部人交易：
Schubach Sarah Elizabeth股份减少1769.00股
|
| 2026-04-07 |
股东大会：
将于2026-05-21召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve an amendment and restatement of our articles of incorporation (our "Articles") to waive jury trials for internal actions, together with contextual and other ministerial changes;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2026-04-07 |
详情>>
股本变动：
变动后总股本23863.85万股
|
| 2026-02-20 |
详情>>
业绩披露：
2023年年报每股收益1.33美元,归母净利润4.54亿美元,同比去年增长-18%
|
| 2026-02-20 |
详情>>
业绩披露：
2025年年报每股收益1.89美元,归母净利润5.08亿美元,同比去年增长12.40%
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益1.46美元,归母净利润4.00亿美元,同比去年增长14.36%
|
| 2025-08-08 |
详情>>
业绩披露：
2025年中报每股收益0.98美元,归母净利润2.76亿美元,同比去年增长13.63%
|
| 2025-05-09 |
详情>>
业绩披露：
2025年一季报每股收益0.52美元,归母净利润1.50亿美元,同比去年增长13.61%
|
| 2025-04-15 |
股东大会：
将于2025-05-15召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2025;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers;
5.To vote on a stockholder proposal to impose vesting provisions on our Class B common stock;
6.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2025-02-21 |
详情>>
业绩披露：
2024年年报每股收益1.42美元,归母净利润4.52亿美元,同比去年增长-0.29%
|
| 2025-02-21 |
详情>>
业绩披露：
2022年年报每股收益1.53美元,归母净利润5.53亿美元,同比去年增长64.74%
|
| 2024-11-08 |
详情>>
业绩披露：
2024年三季报(累计)每股收益1.08美元,归母净利润3.50亿美元,同比去年增长54.44%
|
| 2024-08-09 |
详情>>
业绩披露：
2024年中报每股收益0.74美元,归母净利润2.43亿美元,同比去年增长116.40%
|
| 2024-05-10 |
详情>>
业绩披露：
2024年一季报每股收益0.40美元,归母净利润1.32亿美元,同比去年增长91.74%
|
| 2024-04-02 |
股东大会：
将于2024-05-16召开股东大会
会议内容 ▼▲
- 1.To elect nine directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-04-04 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2023-04-04 |
股东大会：
将于2023-05-18召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2023;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2022-04-05 |
股东大会：
将于2022-05-19召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2022;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-04-06 |
股东大会：
将于2021-05-20召开股东大会
会议内容 ▼▲
- 1.To elect seven directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2021;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2020-04-07 |
股东大会：
将于2020-05-21召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2020;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|
| 2019-04-09 |
股东大会：
将于2019-05-23召开股东大会
会议内容 ▼▲
- 1.To elect eight directors to serve until the next annual meeting of stockholders and until their successors are duly elected and qualified;
2.To ratify the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2019;
3.To approve, on an advisory basis, the compensation of our named executive officers;
4.To approve, on an advisory basis, the frequency of future stockholder advisory votes on the compensation of our named executive officers;
5.To transact such other business as may properly come before the Annual Meeting or any adjournments or postponements thereof.
|